Sep 18

Updates From Prof. Eli Lewis: Advancing Treatments for Type 1 Diabetes

Bethesda, Maryland

This event has passed.
Advancing Treatments for Type 1 Diabetes
Prof. Eli Lewis
Director, Clinical Islet Laboratory at Ben-Gurion University of the Negev
This event has passed.
Monday, September 18, 2017
12:00 p.m. - 2:00 p.m.
At the offices of AABGU
Carr Workplaces
4800 Hampden Lane, Suite 200
Bethesda, Maryland 20814

Light lunch will be served.


R.S.V.P. to David Speer at or 410-205-5408

Prof. Eli Lewis, Ph.D. is breaking new ground in seeking a cure for type 1 diabetes. As the Ilse Katz Career Development Chair in Health Sciences Research at BGU, Prof. Lewis’s work focuses on improving the survival and function of insulin-producing cells in people with diabetes. He and his team recently discovered a common, easily accessible drug that can protect the cells, which reverses diabetes and restores glucose control in animal models. Three clinical trials with people with diabetes have recently been completed. This profound discovery has now been extended to allow successful pancreatic islet cell transplants from animals to benefit people with type 1 diabetes. Prof. Lewis has been awarded prestigious research grants by several foundations, including the Juvenile Diabetes Research Foundation (JDRF) and the Israel Science Foundation.